Literature DB >> 12636932

Effect of vitamin D3 on the conversion of ethylene glycol to glycolate and oxalate in ethylene glycol-fed rats.

A Halabe1, R Shor, N L M Wong, R A L Sutton.   

Abstract

Hypercalciuria and hyperoxaluria are important risk factors in the pathogenesis of kidney stones. Urinary glycolate has also been reported to be elevated in patients with renal stones. 1,25-Dihydroxyvitamin D(3), the active metabolite of vitamin D, has been reported to induce hyperoxaluria after either oral or intravenous administration. 1-alpha-D(3), a synthetic derivative of vitamin D, together with ethylene glycol, has been reported to induce renal stones in experimental rats. We have examined the effect of 1-alpha-vitamin D(3) on urinary oxalate and glycolate excretion. Our results indicate that 1-alpha-D(3), together with ethylene glycol, caused a significant increase in urinary glycolate, without a parallel rise in urinary oxalate excretion, in ethylene glycol-fed rats. This increase in urinary glycolate was due to the synergistic effect of both drugs.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12636932     DOI: 10.1016/s0009-8981(02)00415-1

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  3 in total

1.  Effects of low-molecular-weight polyguluronate sulfate on experimental urolithiasis in rats.

Authors:  Xia Zhao; Guangli Yu; Nan Yue; Huashi Guan
Journal:  Urol Res       Date:  2007-10-11

2.  Biopotency of Acalypha indica Linn on Membrane Bound ATPases and Marker Enzymes urolithic Rats.

Authors:  M Sathya; R Kokilavani; K S Ananta Teepa; A Balakrishnan
Journal:  Anc Sci Life       Date:  2011-07

3.  Antiurolithiatic Effect of Sirupeelai Samoola Kudineer: A Polyherbal Siddha Decoction on Ethylene Glycol-induced Renal Calculus in Experimental Rats.

Authors:  A Hannah Rachel Vasanthi; V Muthulakshmi; V Gayathri; R Manikandan; S Ananthi; Sarah Kuruvilla
Journal:  Pharmacogn Mag       Date:  2017-07-11       Impact factor: 1.085

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.